The move to OTC Pink reduces trading liquidity and institutional visibility. Monitor for potential further deterioration, including possible going-concern disclosures or additional downlisting. Traders should expect wider bid-ask spreads and lower volume.
Price Chart
Executive Summary
ZyVersa Therapeutics (ZVSA) downlisted from the OTCQB Venture Market to the OTC Pink Limited Market effective July 16, 2026. This is a negative signal indicating reduced disclosure standards and likely lower liquidity, which may pressure the stock further.
Key Facts
- Effective July 16, 2026, ZyVersa ceased trading on the OTCQB Venture Market and commenced trading on the OTC Pink Limited Market.
- The company's common stock is now quoted on the OTC Pink Limited Market.
Financial Impact
Downlisting from OTCQB to OTC Pink — no financial figures disclosed in the filing.
Risk Factors
- Reduced liquidity and trading volume on OTC Pink
- Potential loss of remaining institutional or retail interest
- Possible further downlisting or deregistration risk
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001493152-26-033565 |
| Document: 0001493152-26-033565-index-headers.html | 0001493152-26-033565 |
| Document: 0001493152-26-033565-index.html | 0001493152-26-033565 |
| Document: 0001493152-26-033565.txt | 0001493152-26-033565 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Jul 16, 2026 14w ago | 8-K | $0.1150 $0.0800 | ▲ +30.43% | ▲ +35.38% | $0.001000 (+99.13%) |
Mar 5, 2026 33w ago | 8-K | $0.2600 $0.1700 | ▼ −34.62% | ▼ −47.40% | $0.001000 (−99.62%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers